Cartica Acq A (CRTAF) Financials
Newest figures come from the 10-Q for Q3 FY2025, filed Nov 14, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRTAF SEC filings page.
This page shows Cartica Acq Corp A (CRTAF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
Financial Health Signals
We do not publish a peer-relative financial health score for Cartica Acq Corp A, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Cartica Acq Corp A passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Key Financial Metrics
Earnings & Revenue
Cartica Acq Corp A reported a net loss of $3.5M in Q3 2025. This represents a decrease of 5869.0% from the same quarter a year earlier. Against the prior quarter it is down 159.2%.
Not reported for Q3 2025.
Not reported for Q3 2025.
Not reported for Q3 2025.
Cash & Balance Sheet
Cartica Acq Corp A held $2K in cash as of Q3 2025; no long-term debt figure is on record for that period.
Not reported for Q3 2025.
Not reported for Q3 2025.
Margins & Returns
None of these metrics is reported for Q3 2025.
Capital Allocation
Cartica Acq Corp A repurchased no shares in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2025.
Not reported for Q3 2025.
CRTAF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
CRTAF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.8M-35.4% | $16.4M-35.8% | $16.1M-65.8% | $26.4M-43.2% | $26.0M-43.4% | $25.6M-89.6% | $47.0M-80.7% | $46.4M-80.8% |
| Current Assets | $3K-93.9% | $3K-96.9% | $5K-96.4% | $23K-76.7% | $50K-78.0% | $95K-79.9% | $149K-84.8% | $98K-93.1% |
| Cash & Equivalents | $2K-81.3% | $866-95.5% | $2K-93.1% | $2K-76.0% | $10K-51.4% | $19K-90.9% | $35K-95.4% | $8K-99.3% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $29.7M-19.8% | $25.4M-29.8% | $30.7M-42.3% | $41.0M-14.8% | $37.0M-22.2% | $36.2M-82.1% | $53.2M-79.0% | $48.1M-80.8% |
| Current Liabilities | $8.8M+31.1% | $8.2M+47.9% | $7.8M+136.3% | $7.2M+779.2% | $6.7M+1966.9% | $5.5M | $3.3M+1994.2% | $821K+696.6% |
| Non-Current Liabilities | $20.9M-31.1% | $17.2M-43.8% | $22.9M-54.1% | $33.8M-28.6% | $30.3M-35.8% | $30.7M | $49.9M-80.2% | $47.3M-81.1% |
| Total Equity | -$12.9Mn/m | -$9.0Mn/m | -$14.6Mn/m | -$14.6Mn/m | -$11.0Mn/m | -$10.6Mn/m | -$6.2Mn/m | -$1.7Mn/m |
| Retained Earnings | -$13.2Mn/m | -$9.7Mn/m | -$15.7Mn/m | -$16.0Mn/m | -$12.8Mn/m | -$12.9Mn/m | -$8.9Mn/m | -$5.0Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
CRTAF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24Filing | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$229Kn/m | -$188Kn/m | -$230Kn/m | -$388Kn/m | -$114Kn/m | -$716Kn/m | -$336Kn/m | -$163Kn/m |
| Investing Cash Flow | -$202Kn/m | -$162K | $10.4M | -$120Kn/m | -$120K | N/A | N/A | $0n/m |
| Financing Cash Flow | $432K+92.0% | $348Kn/m | -$10.2M-2908.7% | $500K+233.3% | $225K | -$21.1M | $364Kn/m | $150Kn/m |
| Share Buybacks | $0n/m | $0 | $10.6M | N/A | $0 | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.
CRTAF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$14.6M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Cartica Acq Corp A CRTAF | FY2024 | N/A | -$11.0M | N/A | N/A | — |
| Intl Media Acq Corp A IMAQ | FY2026 | N/A | -$345K | N/A | $71.8M | — |
| Chain Bridge I A CBRRF | FY2025 | N/A | -$1.3M | N/A | $63.9M | — |
| Quetta Acquisition Corp QETA | FY2025 | $5.0M | $323K | 6.5% | $43.4M | — |
| Piermont Valley Acq A CMCAF | FY2026 | N/A | -$1.7M | N/A | $77.4M | — |
Where Cartica Acq Corp A Ranks
Frequently Asked Questions
No, Cartica Acq Corp A (CRTAF) reported a net loss of $437K over the trailing 12 months to September 30, 2025. In fiscal year 2024 it reported a net loss of $11.0M.
Cartica Acq Corp A (CRTAF) recorded an outflow of $1.6M in operating cash flow during fiscal year 2024, representing cash used by core business activities.
Cartica Acq Corp A (CRTAF) had $26.4M in total assets as of fiscal year 2024, including both current and long-term assets.
Cartica Acq Corp A (CRTAF) had a current ratio of 0.00 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
Cartica Acq Corp A (CRTAF) had a return on assets of -41.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
Cartica Acq Corp A (CRTAF) has negative shareholder equity of -$14.6M as of fiscal year 2024, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Cartica Acq Corp A (CRTAF) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.